Search Within

Geoffrey R Oxnard

Formats
  1. Journal Article (14)
  2. Meeting Abstract (10)
Groups
  1. Department of Medicine (19)
  2. Solid Tumor Oncology Division (19)
  3. Thoracic Oncology (18)
  4. Department of Pathology and Laboratory Medicine (15)
  5. GSK Faculty (14)
  6. Human Oncology and Pathogenesis Program (14)

More Groups

People
  1. Mark Kris (15)
  2. Marc Ladanyi (14)
  3. Vincent Miller (14)
  4. Maria Arcila (13)
  5. Gregory Riely (9)
  6. William Pao (7)

More People

Years
  1. 2012 (5)
  2. 2011 (10)
  3. 2010 (4)
  4. 2009 (5)
Publications
  1. Clinical Cancer Research (6)
  2. Journal of Clinical Oncology (5)
  3. Journal of Thoracic Oncology (4)
  4. Journal of Molecular Diagnostics (2)
  5. Academic Medicine (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Association for Cancer Research (6)
  2. American Society of Clinical Oncology (5)
  3. Elsevier Inc. (4)
  4. Elsevier Science, Inc. (2)
  5. American Association for the Advancement of Science (1)
  6. C M P Medica LLC * The Oncology Group (1)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes
    Journal Article

    Oxnard, G. R.; Zhao, B.; Sima, C. S.; Ginsberg, M. S.; James, L. P.; Lefkowitz, R. A.; Guo, P.; Kris, M. G.; Schwartz, L. H.; Riely, G. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A window study evaluating the activity of single agent bevacizumab prior to induction chemotherapy for operable non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Paik, P. K.; Oxnard, G. R.; Price, K.; Sima, C. S.; Ginsberg, M. S.; Travis, W. D.; Rusch, V.; Kris, M. G.; Rizvi, N. A.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling
    Journal Article

    Chmielecki, J.; Foo, J.; Oxnard, G. R.; Hutchinson, K.; Ohashi, K.; Somwar, R.; Wang, L.; Amato, K. R.; Arcila, M.; Sos, M. L.; more...
    Science Translational Medicine (2011)

    Fulltext@MSK | Save
  • Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation
    Journal Article

    Oxnard, G. R.; Arcila, M. E.; Sima, C. S.; Riely, G. J.; Chmielecki, J.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay
    Journal Article

    Arcila, M. E.; Oxnard, G. R.; Nafa, K.; Riely, G. J.; Solomon, S. B.; Zakowski, M. F.; Kris, M. G.; Pao, W.; Miller, V. A.; Ladanyi, M.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Clinical course of patients (pts) with acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKI)
    Meeting Abstract

    Oxnard, G. R.; Riely, G. J.; Arcila, M. H.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development
    Journal Article

    Zhao, B.; Oxnard, G. R.; Moskowitz, C. S.; Kris, M. G.; Pao, W.; Guo, P.; Rusch, V.; Ladanyi, M.; Rizvi, N. A.; Schwartz, L. H.
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Use of erlotinib or gefitinib as initial therapy in advanced NSCLC
    Journal Article

    Oxnard, G. R.; Miller, V. A.
    Oncology (Norwalk) (2010)

    Fulltext@MSK | Save
  • Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival
    Journal Article

    Oxnard, G. R.; Schwartz, L. H.
    Cancer (2010)

    Fulltext@MSK | Save
  • A pilot study comparing computerized volume measurement with diameter measurement as an early biomarker of the biologic activity of EGFR targeted therapy
    Meeting Abstract

    Zhao, B. S.; Oxnard, G. R.; Guo, P. Z.; Rizvi, N. A.; Kris, M. G.; Schwartz, L. H.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save